Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Medipost operates an umbilical cord blood bank business (Celltree) and focuses its core business on the development and manufacturing of stem cell therapeutics. Its flagship product is 'Cartistem', a stem cell therapeutic for knee cartilage regeneration. As a biotech company, Medipost also engages in health functional food and cosmetics businesses.
메디포스트는 제대혈은행 사업(셀트리)을 영위하며, 줄기세포 치료제 개발 및 제조를 핵심 사업으로 합니다. 특히 무릎 연골 재생 줄기세포 치료제 '카티스템'을 주요 제품으로 보유하고 있으며, 건강기능식품 및 화장품 사업도 함께 진행하는 바이오 기업입니다.
